Difference between revisions of "PSMD6-AS1"

From LncRNAWiki
Jump to: navigation, search
(Annotated Information)
Line 6: Line 6:
  
 
ENST00000462717<ref name="ref2" />
 
ENST00000462717<ref name="ref2" />
 
===Characteristics===
 
Lnc00462717 is located on chromosome 12 upstream of the MDM2 promoter region<ref name="ref1" />.
 
  
 
===Function===
 
===Function===
lnc00462717 may function in suppressing glioma cell proliferation, survival, migration and may potentially serve as a novel biomarker and therapeutic target for glioma <ref name="ref1" />. lnc00462717 inversely regulates MDM2 expression and plays important roles by partially regulating the MDM2/MAPK pathway in glioma <ref name="ref1" />.
+
lnc00462717 functions in suppressing glioma cell proliferation, survival, migration and may potentially serve as a novel biomarker and therapeutic target for glioma <ref name="ref1" />. lnc00462717 inversely regulates MDM2 expression and plays important roles by partially regulating the MDM2/MAPK pathway in glioma <ref name="ref1" />.
  
 
ENST00000462717 is found to be upregulated in the non-131I-avid lung metastases of Papillary Thyroid Cancer (PTC), and  low expression level of ENST00000462717 is associated with better prognosis of PTC patients with lung metastases <ref name="ref2" />.
 
ENST00000462717 is found to be upregulated in the non-131I-avid lung metastases of Papillary Thyroid Cancer (PTC), and  low expression level of ENST00000462717 is associated with better prognosis of PTC patients with lung metastases <ref name="ref2" />.

Revision as of 08:48, 26 July 2017

Annotated Information

Name

PSMD6-AS1:PSMD6 antisense RNA 1

Lnc00462717[1]

ENST00000462717[2]

Function

lnc00462717 functions in suppressing glioma cell proliferation, survival, migration and may potentially serve as a novel biomarker and therapeutic target for glioma [1]. lnc00462717 inversely regulates MDM2 expression and plays important roles by partially regulating the MDM2/MAPK pathway in glioma [1].

ENST00000462717 is found to be upregulated in the non-131I-avid lung metastases of Papillary Thyroid Cancer (PTC), and low expression level of ENST00000462717 is associated with better prognosis of PTC patients with lung metastases [2].

Diseases

  • Papillary Thyroid Cancer[2]

Labs working on this lncRNA

  • EEG Room, Department of Neurology, Qilu Hospital of Shandong University, Shandong 250012, China
  • Department of Neurology, Qilu Hospital of Shandong University, Shandong 250012, China
  • Department of Medical Insurance Office, Qilu Hospital of Shandong University, Shandong 250012, China[1].
  • Department of Nuclear Medicine, Shanghai Jiao Tong University Affliated Sixth People’s Hospital, Shanghai, China[2].

References

  1. 1.0 1.1 1.2 1.3 1.4 Wang A, Meng M, Zhao X, Kong L. Long non-coding RNA ENST00462717 suppresses the proliferation, survival, and migration by inhibiting MDM2/MAPK pathway in glioma. Biochem Biophys Res Commun. 2017 Apr 1;485(2):513-521.
  2. 2.0 2.1 2.2 2.3 Qiu ZL, Shen CT, Sun ZK, Wei WJ, Zhang XY, Song HJ, Luo QY. Circulating Long Non-Coding RNAs Act as Biomarkers for Predicting 131I Uptake and Mortality in Papillary Thyroid Cancer Patients with Lung Metastases. Cell Physiol Biochem. 2016;40(6):1377-1390.